Mechanisms by which MAGP-2 Promotes Angiogenesis
MAGP-2 促进血管生成的机制
基本信息
- 批准号:7811528
- 负责人:
- 金额:$ 12.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2011-09-29
- 项目状态:已结题
- 来源:
- 关键词:AddressBindingBlood VesselsBlood capillariesCandidate Disease GeneCause of DeathCell membraneCellsCommunicationCytoplasmic GranulesDataData SetEconomicsEmbryoEndothelial CellsEventFundingFunding MechanismsGene Expression ProfileGenesGoalsGrowthGrowth FactorIn VitroIndianaInfiltrationInstitutionInvestmentsLearningMalignant NeoplasmsMedicalMolecularMonitorNeoplasm MetastasisNotch Signaling PathwayPathologic NeovascularizationProbabilityProceduresProteinsRecoveryRegulationResearch PersonnelRoleRuralSignal TransductionSolid NeoplasmStromal CellsStructureStudentsTherapeuticTherapeutic InterventionTrainingTransgenic OrganismsUnited StatesUnited States National Institutes of HealthVascular Endothelial CellZebrafishangiogenesisbasecapillarycombathuman GATA1 proteinhuman microfibrillar-associated protein 2in vivoknock-downlumicannotch proteinnoveloverexpressionparent grantpublic health relevancesuccesstumor
项目摘要
DESCRIPTION (provided by applicant): Angiogenesis is required for the growth and metastasis of cancers. One of the critical events that occur during tumor formation is the remodeling of the angiostatic vascular microenvironment to a pro-angiogenic microenvironment. This remodeling provides pro- angiogenic communications to vascular endothelial cells (ECs) that are critical for normal and pathological angiogenesis. Therefore, therapeutic interventions that disrupt communications between ECs and their microenvironment represent a potential approach for inhibiting angiogenesis and cancer. Unfortunately, there remains a great deal to learn about the microenvironment molecules that regulate angiogenesis and the molecular mechanisms by which these molecules functions. To address this problem, we recently conducted a microarray based transcriptome analysis of ECs undergoing angiogenesis in vitro. We identified 39 secreted proteins that were not previously associated with angiogenesis. Our first analysis of this data set was performed by employing a retroviral overexpression strategy in endothelial cells. Overall, this approach confirmed that two out of seven investigate proteins (i.e. MAGP-2 and lumican) control angiogenesis both in vitro and in vivo. The overall goal of the parent grant to which this revision application is amended is to characterize the molecular mechanisms by which MAGP-2 promotes angiogenesis. We have made significant progress on this project and have determined that MAGP-2 controls angiogenesis by interacting with Notch signaling pathways. Ongoing experimentation in the parent grant is dissecting the molecular details by which MAGP-2 manipulates Notch signaling and the role of endothelial specific MAGP-2 containing granules in angiogenesis regulation. While this project will help us to understand basic aspects of angiogenesis regulation, it does not seek to pursue additional regulators of angiogenesis present within the original microarray data set. This is a missed opportunity since it is highly likely that additional novel regulators of angiogenesis remain to be discovered in our original microarray data. The goal of this revision application is to discover and characterize additional stromal and cell membrane bound regulators of angiogenesis that were not investigated in the initial analysis of our microarray results. This is an important and focused project that based on prior success, has a high probability to uncover novel regulators of angiogenesis. Importantly, in accord with the R15 funding mechanism and the ARRA, the proposed projects will provide outstanding training opportunities for student researchers, will make a strong investment in an institution that has not received significant NIH funding, and therefore will help drive economic recovery in rural Indiana. We propose two specific aims to achieve our goals. In aim 1, we will identify additional stromal and cell membrane bound regulators of angiogenesis. To accomplish this, we will employ a morpholino based knockdown approach of candidate genes in zebrafish embryos to determine if these genes are important regulators of angiogenesis. The effect of gene knockdown will be monitored by microangiogram analysis of Fli1-GFP + GATA-1 RFP double transgenic zebrafish lines. This approach will allow us to rapidly and efficiently screen through the remaining putative regulators of angiogenesis in our original microarray data. Since other regulators of angiogenesis have already been isolated from this dataset, we are confident this project will uncover additional novel angiogenesis regulators. Indeed, as shown in our preliminary results, we have already identified 4 additional putative regulators of angiogenesis using this procedure. In aim 2 these new putative regulators of angiogenesis plus additional genes identified in aim 1 will be monitored for either pro- or anti-angiogenic activities. To accomplish this, candidate genes will be overexpressed and/or knocked down in mammalian endothelial cells and compared to their control counterparts for altered angiogenic activities including cell invasion, proliferation, sensitivity to angiogenic growth factors, and formation of capillary-like structures.
PUBLIC HEALTH RELEVANCE: Cancer continues to be a leading cause of death and suffering in the United States. Since all solid tumors depend on the infiltration of new blood vessels (i.e. angiogenesis), strategies to block angiogenesis may provide therapeutic opportunities to treat cancer. To address this medical need, this proposal seeks to characterize new molecules and mechanisms by which angiogenesis is controlled so that we can one day use this information to block angiogenesis and combat cancer.
描述(由申请人提供):血管生成是癌症生长和转移所必需的。在肿瘤形成期间发生的关键事件之一是将血管生成抑制的血管微环境重塑为促血管生成的微环境。这种重塑为血管内皮细胞(EC)提供了促血管生成的通讯,这对正常和病理性血管生成至关重要。因此,破坏EC与其微环境之间的通信的治疗干预代表了抑制血管生成和癌症的潜在方法。不幸的是,关于调节血管生成的微环境分子以及这些分子发挥作用的分子机制,仍然有很多东西需要了解。为了解决这个问题,我们最近进行了一个基于微阵列的转录组分析的内皮细胞进行血管生成在体外。我们确定了39个分泌蛋白,以前没有与血管生成。我们的第一个分析数据集进行了采用逆转录病毒过表达策略在内皮细胞。总的来说,这种方法证实了七种研究蛋白中的两种(即MAGP-2和lumican)在体外和体内都控制血管生成。本修订申请的母基金的总体目标是表征MAGP-2促进血管生成的分子机制。我们已经在这个项目上取得了重大进展,并确定MAGP-2通过与Notch信号通路相互作用来控制血管生成。在母基金中正在进行的实验是剖析MAGP-2操纵Notch信号传导的分子细节以及含有内皮特异性MAGP-2的颗粒在血管生成调节中的作用。虽然这个项目将帮助我们了解血管生成调控的基本方面,但它并不寻求在原始微阵列数据集中寻找其他血管生成调控因子。这是一个错失的机会,因为它是非常有可能的,其他新的调节血管生成仍然被发现在我们的原始微阵列数据。本修订申请的目的是发现和表征在我们的微阵列结果的初始分析中没有研究的血管生成的额外基质和细胞膜结合调节剂。这是一个重要的和集中的项目,基于先前的成功,有很高的概率发现新的血管生成调节因子。重要的是,在与R15资助机制和ARRA的雅阁中,拟议的项目将为学生研究人员提供出色的培训机会,将对一个尚未获得NIH重大资助的机构进行强有力的投资,因此将有助于推动印第安纳州农村的经济复苏。 我们提出两个具体目标来实现我们的目标。在目标1中,我们将确定额外的基质和细胞膜结合的血管生成调节因子。为了实现这一目标,我们将采用基于吗啉的斑马鱼胚胎候选基因敲除方法,以确定这些基因是否是血管生成的重要调节因子。通过Fli 1-GFP +加塔-1 RFP双转基因斑马鱼系的微血管造影分析来监测基因敲减的效果。这种方法将使我们能够快速有效地筛选出我们原始微阵列数据中剩余的假定血管生成调节因子。由于已经从该数据集中分离出了其他血管生成调节因子,我们相信该项目将发现更多新的血管生成调节因子。事实上,正如我们的初步结果所示,我们已经确定了4个额外的假定的调节血管生成使用这个程序。在目标2中,这些新的假定的血管生成调节因子加上目标1中鉴定的其他基因将被监测促血管生成或抗血管生成活性。为了实现这一点,候选基因将在哺乳动物内皮细胞中过表达和/或敲低,并与它们的对照对应物比较改变的血管生成活性,包括细胞侵袭、增殖、对血管生成生长因子的敏感性和毛细血管样结构的形成。
公共卫生相关性:癌症仍然是美国死亡和痛苦的主要原因。由于所有实体瘤都依赖于新血管的浸润(即血管生成),因此阻断血管生成的策略可以提供治疗癌症的治疗机会。为了满足这一医疗需求,该提案旨在描述控制血管生成的新分子和机制,以便我们有一天可以使用这些信息来阻止血管生成并对抗癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Allan R Albig其他文献
Allan R Albig的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Allan R Albig', 18)}}的其他基金
Investigating tyrosine phosphorylation of Notch proteins
研究 Notch 蛋白的酪氨酸磷酸化
- 批准号:
10578301 - 财政年份:2023
- 资助金额:
$ 12.31万 - 项目类别:
Investigation of a potential MGP negative feedback loop mediated by BMP, Notch,
研究由 BMP、Notch、介导的潜在 MGP 负反馈回路
- 批准号:
8653273 - 财政年份:2014
- 资助金额:
$ 12.31万 - 项目类别:
Identification and Characterization of an Integrin - Notch Signaling Axis
整合素 -Notch 信号轴的鉴定和表征
- 批准号:
9231986 - 财政年份:2012
- 资助金额:
$ 12.31万 - 项目类别:
Identification and Characterization of a Integrin - Notch signaling Axis
整合素 - Notch 信号轴的鉴定和表征
- 批准号:
8367287 - 财政年份:2012
- 资助金额:
$ 12.31万 - 项目类别:
Mechanisms by which MAGP-2 Promotes Angiogenesis
MAGP-2 促进血管生成的机制
- 批准号:
8065215 - 财政年份:2009
- 资助金额:
$ 12.31万 - 项目类别:
Identification of TGF-B regulated angiogenesis genes
TGF-B调节的血管生成基因的鉴定
- 批准号:
6918524 - 财政年份:2003
- 资助金额:
$ 12.31万 - 项目类别:
Identification of TGF-B regulated angiogenesis genes
TGF-B调节的血管生成基因的鉴定
- 批准号:
6793984 - 财政年份:2003
- 资助金额:
$ 12.31万 - 项目类别:
Identification of TGF-B regulated angiogenesis genes
TGF-B调节的血管生成基因的鉴定
- 批准号:
6694872 - 财政年份:2003
- 资助金额:
$ 12.31万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 12.31万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 12.31万 - 项目类别:
Continuing Grant
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 12.31万 - 项目类别:
Discovery Projects
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 12.31万 - 项目类别:
Fellowship
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 12.31万 - 项目类别:
Research Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 12.31万 - 项目类别:
Standard Grant
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 12.31万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 12.31万 - 项目类别:
Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 12.31万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 12.31万 - 项目类别:
Discovery Projects